Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy
Miguel García-Pardo(Hospital Universitario Ramón y Cajal), Natasha B. Leighl(Princess Margaret Cancer Centre), Lucy Corke(University Health Network), Thomas K. Waddell(University Health Network), Noor Ghumman(University Health Network), Laura Donahoe(University Health Network), Adrian G. Sacher(Princess Margaret Cancer Centre), Tracy Stockley(University Health Network), Kazuhiro Yasufuku(University Health Network), Alexandra Salvarrey(University Health Network), Patrik Rogalla(Charité - Universitätsmedizin Berlin), Lisa W. Le(University Health Network), Ming‐Sound Tsao(Kumamoto University), Frances A. Shepherd(University Health Network), Geoffrey Liu(Princess Margaret Cancer Centre), Andrew Pierre(University Health Network), Kasia Czarnecka(University Health Network), Jennifer Law(University Health Network), Penelope A. Bradbury(University Health Network), Prodipto Pal(University Health Network), Roxanne Fernandes(University Health Network), Jason Fan(University Health Network)
Cited by 22
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k